Information about Verovir Pharma
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Verovir Pharma (SA)

BE 0452.353.263

Rue Demoulin(LEE) 3, 6142 Fontaine-l'Evêque
Company information
Status
Active
Enterprise number
BE0452.353.263
VAT liability
Yes
Established
31-03-1994
Last balance sheet year
2023
Company size
Small 0 FTE
Principal activity
Other monetary intermediation
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Verovir Pharma
{{translate("download")}}

Publications in the Belgian Official Journal from Verovir Pharma

Date Publication
11-01-2024 Articles of Association (Translation, Coordination, Other Modifications,...) (FR)
27-10-2016 Resignations, Appointments (FR)
31-07-2006 Conversion in Euro Appointment(s) Modification(s) Articles of Association (FR)
12-01-2002 Augmentation Capital - Euro (FR)
13-04-1994 Constitution (FR)

Frequently asked questions

What is the VAT number of Verovir Pharma?
The VAT number of Verovir Pharma is BE0452353263.
When was Verovir Pharma founded?
Verovir Pharma was founded on 31-03-1994.
What is the address of Verovir Pharma?
The current registered office of Verovir Pharma is located at Rue Demoulin(LEE) 3, 6142 Fontaine-l'Evêque.
When was the last time Verovir Pharma filed their annual financial statements?
The most recent financial statements of Verovir Pharma were filed on 27-06-2024. You can view them here.
How many employees does Verovir Pharma have?
There are currently no employees working at Verovir Pharma or no workforce information is available.
What is the annual turnover of Verovir Pharma?
At the time of its most recent financial statements, Verovir Pharma did not publish any turnover figures. Verovir Pharma reported a gross margin of €70,354.61.

Sources